While different molecular mechanisms of nc886 action in cancer have been proposed, including the modulation of the PKR/NFkB pathway [12, 41] and the generation of microRNAs [16, 17], the relative contribution of nc886 and derived microRNAs in cancer has been hardly addressed in the literature. The gene discussed is EIF2AK2; the disease is cancer.